Use of Routinely Collected "Real-world" Data for the Postlicensure Safety Assessment of Vaccination During Pregnancy

被引：0
|
作者：
Regan, Annette K. [1 ,2 ]
Rowe, Stacey L. [1 ,3 ]
机构：
[1] Univ San Francisco, Sch Nursing & Hlth Profess, Dept Hlth Profess, San Francisco, CA USA
[2] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA USA
[3] Monash Univ, Sch Med Nursing & Hlth Sci, Dept Publ Hlth & Prevent Med, Melbourne, Vic, Australia
来源：
PEDIATRIC INFECTIOUS DISEASE JOURNAL | 2025年 / 44卷 / 02期
关键词：
vaccine safety; pregnancy; maternal vaccination; vaccine surveillance; observational studies; real-world data;
D O I：
10.1097/INF.0000000000004606
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Real-world data can be used to evaluate the postlicensure safety of vaccines during pregnancy. However, these studies often require special design considerations to minimize bias. We offer 4 recommendations for maximizing the use of real-world data for vaccine safety evaluations during pregnancy, including the application of robust methodology, standardized outcome definitions, global collaboration and platforms for data sharing.
引用
收藏
页码：S108 / S110
页数：3
相关论文
共 50 条
  • [31] REAL-WORLD SAFETY AND TOLERABILITY DATA FOR LENVATINIB USE IN UNRESECTABLE HEPATOCELLULAR CANCER
    Celermajer, Yael
    Prince, David S.
    Stratton, Elisabeth
    Davidson, Scott
    Majumdar, Avik
    McCaughan, Geoffrey W.
    Levy, Miriam T.
    Strasser, Simone I.
    Liu, Ken
    HEPATOLOGY, 2020, 72 : 704A - 704A
  • [32] ANNUAL HEALTH INSURANCE TREATMENT COST OF INJURIES TO THE SHOULDER AND UPPER ARM BASED ON ROUTINELY COLLECTED REAL-WORLD FINANCING DATA
    Szots, B.
    Molics, B.
    Kives, Z.
    Gazso, T.
    Varga, V.
    Acs, P.
    Endrei, D.
    Horvath, L.
    Sebestyen, A.
    Boncz, I
    VALUE IN HEALTH, 2020, 23 : S217 - S217
  • [33] ANNUAL HEALTH INSURANCE TREATMENT COST OF FRACTURE OF SKULL AND FACIAL BONES BASED ON ROUTINELY COLLECTED REAL-WORLD FINANCING DATA
    Boncz, I
    Kives, Z.
    Molics, B.
    Gazso, T.
    Kajos, L.
    Szots, B.
    Endrei, D.
    Horvath, L.
    Danku, N.
    Sebestyen, A.
    VALUE IN HEALTH, 2020, 23 : S218 - S218
  • [34] ANNUAL HEALTH INSURANCE TREATMENT COST OF CERVICAL CANCER BASED ON ROUTINELY COLLECTED NATIONWIDE REAL-WORLD FINANCING DATA IN HUNGARY
    Vajda, R.
    Kives, Z.
    Kovacs, S.
    Erdosi, D.
    Boncz, I
    VALUE IN HEALTH, 2020, 23 : S152 - S152
  • [35] New method for determining breast cancer recurrence-free survival using routinely collected real-world health data
    Jung, Hyunmin
    Lu, Mingshan
    Quan, May Lynn
    Cheung, Winson Y.
    Kong, Shiying
    Lupichuk, Sasha
    Feng, Yuanchao
    Xu, Yuan
    BMC CANCER, 2022, 22 (01)
  • [36] Real-world evidence in safety assessment of new treatments
    Smedby, Karin E.
    Eloranta, Sandra
    LANCET HAEMATOLOGY, 2018, 5 (11): : E510 - E511
  • [37] THE USE OF REAL-WORLD DATA IN HEALTH TECHNOLOGY ASSESSMENT OF MEDICATIONS FOR RARE DISEASES
    Harwood, M.
    Deighton, A.
    Mickle, A.
    Qian, C.
    Szabo, S.
    VALUE IN HEALTH, 2019, 22 : S863 - S863
  • [38] Demographic clinical trial diversity assessment methods: Use of real-world data
    Chen, Hua
    Emechebe, Nnadozie
    Karve, Sudeep
    Raskin, Leon
    Leal, Jailene
    Cheng, Ning
    Sebby, Wendy
    Ribeiro, Kim
    Crawford, Samuel
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2025, 44
  • [39] The use of real-world data in drug repurposing
    Park, Kyungsoo
    TRANSLATIONAL AND CLINICAL PHARMACOLOGY, 2021, 29 (03) : 117 - 124
  • [40] The use of real-world data in health technology assessment of medications for rare diseases
    Qian, Christina J.
    Mickle, Alexis T.
    Deighton, Alison M.
    Harwood, Meagan M.
    Szabo, Shelagh M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 259 - 259
12345